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Introduction: Four-dimensional computed tomography (4DCT) is
currently being introduced to radiotherapy centers worldwide, for
use in radical radiotherapy planning for non-small cell lung cancer
(NSCLC). A significant drawback is the time required to delineate
10 individual CT scans for each patient. Every department will
hence ask the question if the single Maximum Intensity Projection
(MIP) scan can be used as an alternative. Although the problems
regarding the use of the MIP in node-positive disease have been
discussed in the literature, a comprehensive study assessing its use
has not been published. We compared an internal target volume
(ITV) created using the MIP to an ITV created from the composite
volume of 10 clinical target volumes (CTVs) delineated on the 10
phases of the 4DCT.
Methods: 4DCT data was collected from 14 patients with NSCLC.
In each patient, the ITV was delineated on the MIP image
(ITV_MIP) and a composite ITV created from the 10 CTVs delin-
eated on each of the 10 scans in the dataset. The structures were
compared by assessment of volumes of overlap and exclusion.
Results: There was a median of 19.0% (range, 5.5–35.4%) of the
volume of ITV_10phase not enclosed by the ITV_MIP, demonstrat-
ing that the use of the MIP could result in under-treatment of
disease. In contrast only a very small amount of the ITV_MIP was
not enclosed by the ITV_10phase (median of 2.3%, range, 0.4–
9.8%), indicating the ITV_10phase covers almost all of the tumor
tissue as identified by MIP. Although there were only two Stage I
patients, both demonstrated very similar ITV_10phase and
ITV_MIP volumes. These findings suggest that Stage I NSCLC
tumors could be outlined on the MIP alone. In Stage II and III
tumors the ITV_10phase would be more reliable.
Conclusions: To prevent under-treatment of disease, the MIP image
can only be used for delineation in Stage I tumors.
Key Words: 4DCT scans, Maximum intensity projections, Lung
cancer, Internal target volume.
(J Thorac Oncol. 2008;3: 1433–1438)
The intrafraction movement of non-small cell lung cancer(NSCLC) tumors during planning for radical radiother-
apy, is encompassed within the margin between the clinical
target volume (CTV) and the internal target volume (ITV).
With the traditional method of using 3D Helical computed
tomography (CT) scans for conformal planning, the intrafraction
movement, due primarily to respiration, is not measurable.
Therefore a standard “population-based margin” is applied. The
margin applied is crudely assessed using fluoroscopy at the
radiotherapy simulator and altered only if the tumor is obvi-
ously moving out with the planned target volume (PTV). To
account for the significant interpatient variability, there is
increasing evidence supporting the use of Four-dimensional
CT scanning (4DCT) to apply a patient-specific CTV to ITV
margin.1–4
4DCT is a single investigation generating spatial and
temporal information on mobility.5,6 It has been shown to be a
better method of assessing respiratory movement than previ-
ously used fluoroscopy7 or the use of six, standard 3DCT’s, in
combination.8 The use of 4DCT to individualize the CTV to ITV
margins has been shown to improve tumor localization and
potentially decrease normal tissue irradiation.9,10
Various methods of creating an ITV from a 4DCT dataset
have been reported. The first, most robust, but time consuming
method, is to create 10 images representing 10 phases of the
respiratory cycle from the 4DCT dataset. To create an ITV from
the 10 phases (ITV_10phase), all 10 image sets must be con-
toured creating 10 CTVs. An ITV is created by encompassing
the CTVs from each of the 10 phases. As radiotherapy centers
implement 4DCT into planning, a limiting factor to clinical use,
is the time taken to delineate 10 scans on each patient. Another
delineating method, which to those introducing 4DCT may be
an obvious alternative, is to use a Maximum Intensity Projection
(MIP).11,12 This is a single image created by the 4DCT dataset.
This reflects, the highest density value encountered in each pixel
throughout the respiratory cycle. One of the first questions that
will be asked by centers implementing 4DCT is whether the
MIP encompasses enough of the ITV_10phase for it to be used
safely, as the obvious advantage of this method is that once
produced, it is one CT scan that should take no longer to volume
than the current 3D helical scans.
There is conflicting evidence in the literature regarding
the use of MIPs for delineation. Underberg et al.11 compared
ITV_MIP with ITV_10phase in 12 patients with Stage I lung
tumors. They concluded that contouring of MIP scans was a
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reliable and fast clinical tool for generating ITVs. In the
discussion, concerns were raised regarding the use of MIP in
more advanced tumors. Ezhil et al.12 compared ITV_MIP to
ITV_10phase in 27 patients with Stage I–III NSCLC. They
concluded that for all stages of disease, the ITV_MIP was
significantly smaller in volume than the ITV_10phase. We
feel there is a lack of a comprehensive study with a particular
interest in locally advanced tumors, to answer this question,
which will be asked repeatedly as 4DCT is implemented into
clinical care.
PATIENTS AND METHODS
CT Image Acquisition
All patients were immobilized using a Sinmed Posirest
Thoracic Board (Sinmed BV, The Netherlands) and a knee
support, on a GE Lightspeed RT 16 Multislice CT scanner
(GE Healthcare, UK). Fifty milliliters of Omnipaque 300
intravenous contrast was administered by Stellant Contrast
Injector. A helical scan was acquired followed immediately
by a 4DCT. Patients were asked to breathe freely throughout
and scans covered the whole chest cavity.
4DCT scanning was performed using the Varian Real-
Time Positioning Management System (RPM; Varian Medi-
cal Systems, Palo Alto, CA). Scanning parameters were set at
120 kV, 20 mA with a slice thickness of 2.5 mm. A block
containing infrared-reflecting markers was placed on the
patients’ xiphisternum to monitor respiration. The motion of
the block was captured by a camera fixed to the end of the
treatment couch and a respiratory signal was displayed in the
control room. For each patient the respiratory cycle was
assessed. The cine duration, which is the period of time for
which the couch is static and image sets are acquired, was set
as the mean respiratory cycle length for that patient plus 0.5
seconds. The radiograph tube rotation was set to 1/10th of the
respiratory cycle length. In each static couch position, 8
contiguous slices of 2.5 mm were acquired. The couch
position was indexed by 20 mm and the process repeated.
Mean respiratory cycle lengths ranged from 2.9 to 7.9 sec-
onds. The helical scan acquisition time was about 18 seconds
and the 4DCT acquisition time was about 90 seconds.
The 4DCT dataset was transferred to an Advantage 4D
workstation (GE Healthcare, UK) where a software package
was used to create 10 different scan sets relating to 10
sequential phases of the respiratory cycle, using the ampli-
tude of the respiratory trace. These are labeled 0%, 10%,
. . . ., 90%. The 0% phase is at maximum inhalation and
maximum exhalation is at 50 to 60%. The 4D software is also
used to create a MIP scan from the raw data. In the MIP, each
pixel is assigned the highest density value that occurred,
taking account of all 10 scan phases. For a solid tumor
moving within low density lung tissue, this process gives a
good representation of the volume occupied by the tumor
throughout the respiratory cycle.
Patient Selection
This was a retrospective analysis for patients who had
undergone both Helical and 4DCT for their radical radiother-
apy planning. Fourteen consecutive patients, presenting to
one consultant with radically treatable NSCLC, over a 4
month period, were studied. Tumor stages varied from Stage
IB to Stage IIIB (Table 1).
Generating Target Volumes
The target outlining in all 14 patients was completed by
the same experienced radiation oncologist. 4DCT and helical
scans were transferred to the Varian Eclipse Treatment Plan-
ning System, software version 6.5 (Varian Medical Systems,
Palo Alto, CA). The scans were viewed and outlined in
standard mediastinal and lung window settings (130HU to
200HU and 1000HU to 200HU, respectively). The
CTV’s of the primary tumor included all gross disease, with
a margin of around 3 mm. Lymph nodes were included if they
measured1 cm in diameter and were also given a margin of
around 2 to 3 mm to account for microscopic disease.
The disease outlined on the MIP image includes allow-
ance for movement of the structure and was delineated with
a margin of approximately 3 mm for microscopic disease.
This created an ITV and was labeled ITV_MIP.
To create the composite volume from all 10 phases
(ITV_10phase), each of the 10 phase image sets was con-
toured individually to create 10 CTVs. To produce a com-
posite structure, each phase image had to be registered in turn
with a reference image, in this case 0%. The image sets were
already DICOM matched, having been acquired from the
same scan, but the inflexibility of the software package added
to the time required for this process. The CTVs from each
phase were copied onto the reference image and algebraic
operators were used to create the ITV_10phase.
The MIP image was also registered with the reference
image (0%) and the ITV_MIP was copied across so that it
could be compared directly with the ITV_10phase.
Analysis of Target Volumes
The volumes of the two ITVs were compared by calcu-
lating the ratio between them. The areas on the scan where the
TABLE 1. Tumor Characteristics
Patient
TNM
Stage Stage Position
Patient A T2 N0 Stage IB LLL
Patient B T2 N0 Stage IB LUL
Patient C T2 N2 Stage IIIA RML. Partial collapse of RML
Patient D T4 N0 Stage IIIB Rt pancoast tumor
Patient E T4 N2 Stage IIIB Rt pancoast tumor
Patient F T2 N1 Stage IIB RUL. Collapsed RUL
Patient G T2 T2 Stage IIIA RML. Adjacent to hilum
Patient H T4 N2 Stage IIIB LLL. Infiltrating pulmonary artery
Patient I T1 N2 Stage IIIA LUL. Adjacent to hilum
Patient J T2 N2 Stage IIIA RLL. Adherent to diaphragm
Patient K T2 N1 Stage IIB RML. Adjacent to hilum
Patient L T0 N2 Stage IIIA Mediastinal recurrence following
lobectomy
Patient M T2 N1 Stage IIB RUL
Patient N T2 N1 Stage IIB RML. Adjacent to hilum
TNM, tumor, node, metastasis; RUL, right upper lobe; RML, right middle lobe;
RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe.
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volumes most differed were noted. Algebraic operators were
used on the Varian Eclipse system to determine the volume of
tissue enclosed by the ITV_10phase but not by ITV_MIP and,
likewise, the volume of tissue enclosed by the ITV_MIP but not
the ITV_10phase. The center of mass co-ordinates (COM co-
ordinates) of both volumes were recorded and compared.
Statistical Analysis
Wilcoxon signed-rank test, calculated on SPSS 15.0 for
Windows, was used to compare volumes. A p  0.05 would
be considered statistically significant.
RESULTS
Comparison of ITV_10phase to ITV_MIP
In all patients the ITV_10phase was equal or larger than
the ITV_MIP. The mean ratio (SD) of ITV_10phase/
ITV_MIP was 1.23  0.17 (Table 2). The 95% confidence
interval was between 1.13 and 1.32. The Wilcoxon Signed-
Rank test showed there was a statistically significant differ-
ence between the 2 volumes (p  0.001).
The median percentage of ITV_10phase, or potentially
tumor tissue, which was not covered by the ITV_MIP, was
19.0% (range, 5.5–35.4%) (Table 3). There was good agreement
in delineation in areas where the higher density tumor adjoined
lower density lung tissue. However, significant differences in
delineation occurred where tumor adjoined the mediastinum or
diaphragm i.e., where the tissue has a similar density to tumor.
This is demonstrated in Figure 1. The median percentage of
ITV_MIP that was not covered by ITV_10phase was 2.3%
(range, 0.4–9.8%) (Table 4). These areas were randomly dis-
tributed around the circumference of the volume and relate to
very small displacements of the contour lines.
In the two patients with Stage I disease (Patients A and B),
the ITV_MIP and ITV_10phase volumes were very similar with
the ratios of 1.01 and 1.04 (Table 2). Only 6.8% and 5.4% of
ITV_10phase was not enclosed by MIP (Table 3). These tumors
were entirely surrounded by low density lung tissue and contour
lines were again displaced by very small distances.
The COM co-ordinates and calculated displacement of
centers are shown in Table 5. In the superior/inferior axis,
medio-lateral axis and anterior/posterior axis the mean dis-
tance between co-ordinates was 0.15 cm, 0.13 cm, and 0.07
cm, respectively. The mean (SD) displacement of the cen-
TABLE 2. Comparison of ITV_10phase to ITV_MIP
ITV_10phase
(cm3)
ITV_MIP
(cm3)
Difference in
Volumes (cm3)
ITV_10phase/
ITV_MIP
Patient A 37.0 36.8 0.2 1.01
Patient B 26.0 24.9 1.1 1.04
Patient C 140.1 116.2 23.9 1.21
Patient D 96.2 80.4 15.8 1.20
Patient E 67.2 52.2 15.0 1.29
Patient F 120.1 94.3 25.8 1.27
Patient G 111.4 91.5 19.9 1.22
Patient H 99.4 87.5 11.9 1.14
Patient I 112.5 87.3 25.2 1.29
Patient J 215.8 138.9 76.9 1.55
Patient K 71.2 63.2 8.0 1.13
Patient L 40.4 26.2 14.2 1.54
Patient M 51.7 39.0 12.7 1.33
Patient N 37.2 37.0 0.2 1.01
Mean  SD 1.23  0.17
Median 1.22
p value 0.001
ITV, internal target volume; MIP, maximum intensity projection.
TABLE 3. The Percentage Volume Covered by ITV_10phase
that Remained Uncovered by ITV_MIP
Volume of
ITV_10phase
Not Encompassed
by ITV_MIP (cm3)
Volume of
ITV_10phase
(cm3)
% of ITV_10phase
Not Encompassed
by ITV_MIP
Patient A 2.5 37.0 6.8
Patient B 1.4 26.0 5.5
Patient C 30.9 140.1 22.1
Patient D 11.6 96.2 12.1
Patient E 15.0 67.2 22.3
Patient F 23.1 120.1 19.2
Patient G 17.2 111.4 15.4
Patient H 18.0 99.4 18.1
Patient I 25.1 112.5 22.3
Patient J 76.4 215.8 35.4
Patient K 13.4 71.2 18.8
Patient L 13.0 40.4 32.2
Patient M 11.4 51.7 22.1
Patient N 2.5 37.2 6.6
Mean  SD 18.5  8.5
Median 19.0
ITV, internal target volume; MIP, maximum intensity projection.
FIGURE 1. An illustration of differences between ITV_MIP
(blue) and ITV_10phase (purple) when tumor is adjacent to
higher density tissue.
Journal of Thoracic Oncology • Volume 3, Number 12, December 2008 Maximum Intensity Projections
Copyright © 2008 by the International Association for the Study of Lung Cancer 1435
ters was calculated as 0.34 cm (0.31). There were 5 patients
with a displacement of COM of more than or equal to 0.4 cm.
This level of displacement would cause a significant system-
atic error affecting ITV to PTV margin.
DISCUSSION
This study suggests that ITV_MIP cannot be used for
accurate delineation of Stage II–III tumors as there are
significant volumes of tumor tissue, identified by the
ITV_10phase, that are not encompassed by the ITV_MIP. In
contrast, ITV_MIP could be used for Stage I tumors but this
is based on data from only two patients.
The use of MIP in Stage I tumors is in keeping with the
findings of Underberg et al.11 that an ITV created using a MIP
image is reliable. The concerns regarding locally advanced
tumors mentioned in that discussion are corroborated by this
study. Figure 1, used to illustrate the problems with MIP in
locally advanced tumors, resembles the image used in the
discussion of the Underberg paper. It is reassuring to note that
even given the different observers and patient group, the
conclusion remains the same.
For those with experience in the use of 4DCT datasets,
this is not a surprising finding. For most Stage 1 NSCLC, a
discrete tumor mass moves within much lower density lung
tissue, allowing large differences in density providing obvi-
ous contour lines. For Stage II–III and above, the tumor mass
will be adjacent, at least on some boundaries, to tissue of
equal density, such as mediastinum, chest wall or diaphragm.
A boundary between tumor and normal tissue may be clearly
visible on any individual phase scan. On the MIP image,
boundaries become blurred. There is a natural tendency
towards presuming that tissue is ‘normal’ unless there is
evidence to show otherwise and so the extent of disease tends
to be underestimated on the MIP. It is possible that individual
nodes may not be identified. For those beginning to use
4DCT this is an important point to highlight, and a further
discussion regarding alternative delineation techniques will
take place in more detail below.
The information from a diagnostic PET/CT was not
available for this group of patients as its routine use had not
been introduced at the time of the planning scans. Although
the use of PET/CT has a significant effect on interclinician
variability,13 it should not have an effect on intraclinician
variability. As there is no consensus on what level of SUV, or
percentage of SUV, constitutes the tumor edge,14,15 currently
it should be used for localization purposes rather than delin-
eation. Although it may have highlighted different nodal
groups, hence increasing the ITVs, the intraobserver variation
would be the same, hence generating the same outcome.
The intraobserver variation explains why in all cases
the ITV_10phase is bigger than ITV_MIP. Intraobserver
variations in PTV are reported to vary from 3.9 to 95.8 cm3,16
and as a result, on producing the composite ITV_10phase the
largest CTV is selected from each position. As a result, small
differences in ITVs such as 0.2 cm3 or 1.1 cm3, as in the
Stage I tumors, are likely due only to intraobserver variation,
rather than a difficulty in delineating the tumor.
The creation of the CTV in the above manner, with
gross tumor and an additional margin of approximately 3
mm, was adopted as a standard throughout all patients. It is
widely accepted that interclinician discrepancies remain
high.14,17 This includes divided opinion on the margin for
micrometastatic disease, the margin for extracapsular spread
of lymph nodes and whether only involved nodes or nodal
stations should be delineated.18–21 The decision as to which
lymph nodes the clinician aims to treat, can be improved by
the use of PET/CT scans and improved staging with lymph
TABLE 4. The Percentage Volume Covered by ITV_MIP that
is Uncovered by ITV_10phase
Volume of ITV_MIP
Not Encompassed by
ITV_10phase (cm3)
Volume of
ITV_MIP
(cm3)
% of ITV_MIP Not
Encompassed by
ITV_10phase
Patient A 1.3 36.8 3.6
Patient B 0.2 24.9 0.9
Patient C 2.0 116.2 1.7
Patient D 0.3 80.4 0.4
Patient E 2.5 52.2 4.9
Patient F 0.5 94.3 0.6
Patient G 0.5 91.5 0.5
Patient H 7.5 87.5 8.6
Patient I 1.9 87.3 2.2
Patient J 3.5 138.9 2.6
Patient K 6.2 63.2 9.8
Patient L 0.6 26.2 2.4
Patient M 0.7 39.0 1.7
Patient N 2.7 37.0 7.4
Mean  SD 3.4  3.0
Median 2.3
ITV, internal target volume; MIP, maximum intensity projection.
TABLE 5. The COM Co-ordinates in the Two Different
Volumes (cm)
ITV_10phase
x, y, z
ITV_MIP
x, y, z
Distance between
Centers (cm)
Patient A 3.5, 1.5, 1.3 3.9, 1.8, 1.3 0.45
Patient B 6.9, 8.1, 7.8 6.9, 8.1, 7.9 0.06
Patient C 6.0, 4.2, 1.0 6.2, 4.2, 1.0 0.23
Patient D 6.7, 5.0, 11.7 6.7, 5.0, 11.8 0.10
Patient E 5.0, 1.5, 7.6 5.5, 1.7, 8.5 1.05
Patient F 3.7, 0.2, 6.2 3.7, 0.0, 6.3 0.11
Patient G 2.7, 0.1, 1.0 2.7, 0.0, 1.1 0.13
Patient H 8.6, 5.5, 3.3 8.6, 5.5, 3.3 0.04
Patient I 5.2, 0.5, 0.1 5.5, 0.4, 0.2 0.45
Patient J 7.0, 0.3, 2.2 6.3, 0.1, 1.6 0.96
Patient K 8.3, 3.0, 0.8 8.7, 3.3, 1.0 0.53
Patient L 0.9, 1.4, 4.8 0.9, 1.5, 4.6 0.21
Patient M 4.6, 1.5, 7.0 4.8, 1.7, 7.0 0.25
Patient N 5.8, 0.4, 3.6 5.7, 0.4, 3.5 0.16
Mean  SD 0.34  0.31
Median 0.22
x, left/right axis; y, anterior/posterior axis; z, superior/inferior axis.
ITV, internal target volume; MIP, maximum intensity projection; COM, center of mass.
Muirhead et al. Journal of Thoracic Oncology • Volume 3, Number 12, December 2008
Copyright © 2008 by the International Association for the Study of Lung Cancer1436
node sampling. However, irrelevant of the lymph nodes the
clinician intents to delineate, lymph nodes cannot be accu-
rately delineated on a MIP image as the contour lines between
the nodes and the surrounding soft tissue are lost. The above
study remains valid as there was a consistent method used
throughout all the delineation.
The major practical drawback to the use of
ITV_10phase is the operator time required. Delineation of 10
scans and creation of composite volumes takes on average 2.5
hours per patient and it is very desirable to reduce this time
requirement. A number of alternative methods have been
reported in the literature:
Y Ezhil et al.11 described the creation of a structure labeled
ITV_MIP_Modified. The CTV was delineated on the
MIP image and this volume was superimposed onto
each of the 10 phases in turn, where it was modified by
enlarging boundaries as appropriate. The ITV_MIP_
Modified was in close agreement with ITV_10phase.
This could offer some time savings but remains a work
intensive method. We found that the requirement to
match scan sets in pairs added significantly to the time
required. Improvements to computer software could per-
mit direct matching across multiple image sets espe-
cially where they are already DICOM matched i.e., they
have been acquired in the same scan process.
Y A number of studies created an ITV from a composite of
the two scans with the tumor in the most superior and
inferior position.22,23 There are a number of concerns
with this method. This does not take into account lateral
or anterior/posterior motion of the tumor nor hysteresis.
There is also evidence describing the lack of correlation
between the primary tumor and lymph node move-
ment.24,25 When selecting the two scans for delineation
it may be that the primary tumor and involved lymph
nodes are at their craniocaudal extreme positions in
different scans. Care must also be taken to review the
4DCT cinescan in all planes. The method can be used if
careful review of the 4D window cinescan takes place,
in all planes, noting any areas of significant movement
in other directions. A margin could be added to the ITV
to PTV margin for the additional movement and hyster-
esis that takes place as above. Unless used with care and
experience, this technique could lead to geographical
miss of disease.
Y Wolthaus et al.3 reported a method for constructing a
single CT scan from the 4D dataset which represents the
tumor in its time-averaged position over the respiratory
cycle (midventilation scan). While diaphragm move-
ment could be used to quickly identify the midventila-
tion scan for Stage I tumors, for Stage II and III disease,
delineation of all 10 phases was required, which is the
time-consuming process we are trying to avoid.
Y Bosmans et al.4 described a method where the 4D
cinescan is used to identify the scan where the tumor is
in its central position and measure the motion of the
tumor in all three orthogonal directions. After delineat-
ing a CTV on the half ventilation scan individual mar-
gins are added which are calculated using the motion
seen on the 4D cinescan. The volumes created in this
method are comparable in the above paper. Again, if
awareness that the movement of the tumor will vary
dependant on the plane it is reviewed in and that primary
tumor and lymph nodes move individually, this is a
feasible alternative method.
Y There are a number of other methods reported, using
different imaging techniques for individualizing margins
including; slow CT,25 end-tidal breath-hold CTs,26 com-
posite of two different helical scans in maximal inhale
and exhale27 and breath-hold CT,28 however, each of
these have their drawbacks and as software and systems
have moved on, the 4DCT dataset is now regarded as the
gold standard.
Although there is evidence that normal tissue irradia-
tion is reduced and target localization improves with the use
of individualized margins, it has to be noted there is a lack of
clinical outcome data. As with the introduction of conformal
radiotherapy, there is a general consensus within clinical
circles that this constitutes an improvement from current
techniques and a randomized control trial of 3D versus 4D
planning scans may be difficult to recruit to on ethical
grounds. Clinicians may feel 3D planning scan may consti-
tute suboptimal treatment. Hence a comparative study with
outcome data and cost effectiveness data is unlikely to occur.
In conclusion, in the meantime, in our center, we
propose the use of the MIP image target delineation for
patients with Stage 1 disease. For Stage II and III disease we
propose delineation using all 10 scan phases described herein,
until sufficient confidence has been gained that the other
methods as discussed above, can be considered.
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